| scholarly article | Q13442814 |
| P50 | author | Irene Oi-lin Ng | Q67487913 |
| Terence Kin-Wah Lee | Q73885432 | ||
| Regina C L Lo | Q80738812 | ||
| P2093 | author name string | Alan Ka-Lun Kai | |
| Carmen Oi-Ning Leung | |||
| Kwan-Shuen Chan | |||
| Wing-Nga Mak | |||
| P2860 | cites work | Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity | Q24292793 |
| MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. | Q53261686 | ||
| Analysis of SOX9 expression in colorectal cancer. | Q54506833 | ||
| Cancer stem cells | Q80312237 | ||
| Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis | Q82299264 | ||
| Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells | Q24320123 | ||
| Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
| Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors | Q24676478 | ||
| Frizzled7 as an emerging target for cancer therapy | Q26849278 | ||
| β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis | Q28087660 | ||
| Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness | Q28236570 | ||
| Hypoxia and regulation of cancer cell stemness | Q33705149 | ||
| Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma | Q33976991 | ||
| Slug and Sox9 cooperatively determine the mammary stem cell state | Q34030957 | ||
| Hippo pathway activity influences liver cell fate | Q34060093 | ||
| Interactions between cancer stem cells and their niche govern metastatic colonization | Q34239769 | ||
| beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. | Q34302259 | ||
| SOXs in human prostate cancer: implication as progression and prognosis factors. | Q34306308 | ||
| Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. | Q34630557 | ||
| Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival | Q35856469 | ||
| Oncogenicity of the developmental transcription factor Sox9. | Q36043468 | ||
| Sox9 is required for prostate development and prostate cancer initiation | Q36234048 | ||
| Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma | Q36299435 | ||
| Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice | Q36421780 | ||
| SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer | Q36647355 | ||
| Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma | Q36755188 | ||
| Cancer stem cells in the development of liver cancer | Q36793453 | ||
| Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells | Q37179115 | ||
| SOX9: a stem cell transcriptional regulator of secreted niche signaling factors | Q37608199 | ||
| Epigenetic signatures in stem cells and cancer stem cells. | Q37961998 | ||
| Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma. | Q38009569 | ||
| SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling | Q38906000 | ||
| β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma | Q38993024 | ||
| CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation | Q39512947 | ||
| Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma | Q40385782 | ||
| The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. | Q40461728 | ||
| Frizzled7 functions as a Wnt receptor in intestinal epithelial Lgr5(+) stem cells | Q40843426 | ||
| Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties | Q42030667 | ||
| Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma | Q42557385 | ||
| SOX9 regulates endocrine cell differentiation during human fetal pancreas development. | Q51851391 | ||
| Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. | Q51894736 | ||
| SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 29371-29386 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling | |
| P478 | volume | 7 |
| Q92554204 | A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway |
| Q93004356 | Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside |
| Q53708414 | Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway. |
| Q48526220 | Deregulation of Frizzled Receptors in Hepatocellular Carcinoma. |
| Q64105262 | Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma |
| Q33276544 | Expression and Therapeutic Potential of SOX9 in Chordoma |
| Q98158767 | Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling |
| Q55080511 | Frizzled Receptors as Potential Therapeutic Targets in Human Cancers. |
| Q90308396 | In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness properties |
| Q64055307 | Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells |
| Q47095936 | Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9. |
| Q98906859 | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
| Q64106031 | Notch Inhibition Promotes Differentiation of Liver Progenitor Cells into Hepatocytes via Repression in Zebrafish |
| Q52585710 | Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin. |
| Q64095213 | SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer |
| Q93016744 | SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance |
| Q47094928 | SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types. |
| Q91756222 | SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells |
| Q52764125 | Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns. |
| Q37692443 | Sox9 transcriptionally regulates Wnt signaling in intestinal epithelial stem cells in hypomethylated crypts in the diabetic state |
| Q50916178 | Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma. |
| Q97075825 | The Hepatic Sinusoid in Aging and Disease: Update and Advances From the 20th Liver Sinusoid Meeting |
| Q38604538 | Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway |
| Q38648415 | Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma - an immunohistochemical study. |
| Q48513742 | cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. |
| Q64262257 | miR-135 regulated breast cancer proliferation and epithelial-mesenchymal transition acts by the Wnt/β-catenin signaling pathway |
| Q46735091 | β-Catenin Deficiency in Hepatocytes Aggravates Hepatocarcinogenesis Driven by Oncogenic β-Catenin and MET. |
Search more.